<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83205</article-id><article-id pub-id-type="doi">10.7554/eLife.83205</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>Reserpine maintains photoreceptor survival in retinal ciliopathy by resolving proteostasis imbalance and ciliogenesis defects</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-292107"><name><surname>Chen</surname><given-names>Holly Y</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-292109"><name><surname>Swaroop</surname><given-names>Manju</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-292116"><name><surname>Papal</surname><given-names>Samantha</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9417-6215</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-292110"><name><surname>Mondal</surname><given-names>Anupam</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-306995"><name><surname>Song</surname><given-names>Hyun Beom</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-306996"><name><surname>Campello</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292108"><name><surname>Tawa</surname><given-names>Gregory</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-292111"><name><surname>Regent</surname><given-names>Florian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292112"><name><surname>Shimada</surname><given-names>Hiroko</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292115"><name><surname>Nagashima</surname><given-names>Kunio</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292113"><name><surname>de Val</surname><given-names>Natalia</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292114"><name><surname>Jacobson</surname><given-names>Samuel G</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-64320"><name><surname>Zheng</surname><given-names>Wei</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1034-0757</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" corresp="yes" id="author-62419"><name><surname>Swaroop</surname><given-names>Anand</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1975-1141</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf8"/></contrib><aff id="aff1"><institution content-type="dept">Neurobiology, Neurodegeneration and Repair Laboratory</institution>, <institution>National Eye Institute</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">National Therapeutics for Rare and Neglected Diseases</institution>, <institution>National Center for Advancing Translational Sciences</institution>, <addr-line><named-content content-type="city">Rockville</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Electron Microscopy Laboratory</institution>, <institution>Frederick National Laboratory for Cancer Research</institution>, <addr-line><named-content content-type="city">Frederick</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Ophthalmology</institution>, <institution>University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-17808"><name><surname>Fu</surname><given-names>Zhongjie</given-names></name><role>Reviewing editor</role><aff><institution>Boston Children's Hospital</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>swaroopa@nei.nih.gov</email> (AS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>03</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e83205</elocation-id><history><date date-type="received"><day>02</day><month>09</month><year>2022</year></date><date date-type="accepted"><day>23</day><month>03</month><year>2023</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83205-v1.pdf"/><abstract><p>Ciliopathies manifest from sensory abnormalities to syndromic disorders with multi-organ pathologies, with retinal degeneration a highly penetrant phenotype. Photoreceptor cell death is a major cause of incurable blindness in retinal ciliopathies. To identify drug candidates to maintain photoreceptor survival, we performed an unbiased, high-throughput screening of over 6,000 bioactive small molecules using retinal organoids differentiated from induced pluripotent stem cells (iPSC) of <italic>rd16</italic> mouse, which is a model of Leber congenital amaurosis (LCA) type 10 caused by mutations in the cilia-centrosomal gene <italic>CEP290</italic>. We identified five non-toxic positive hits, including the lead molecule reserpine, which maintained photoreceptor development and survival in <italic>rd16</italic> organoids. Reserpine also improved photoreceptors in retinal organoids derived from induced pluripotent stem cells of <italic>LCA10 </italic>patients and in <italic>rd16 </italic>mouse retina <italic>in vivo</italic>. Reserpine-treated patient organoids revealed modulation of signaling pathways related to cell survival/death, metabolism, and proteostasis. Further investigation uncovered dysregulation of autophagy associated with compromised primary cilium biogenesis in patient organoids and <italic>rd16</italic> mouse retina. Reserpine partially restored the balance between autophagy and the ubiquitin-proteasome system at least in part by increasing the cargo adaptor p62, resulting in improved primary cilium assembly. Our study identifies effective drug candidates in preclinical studies of <italic>CEP290</italic> retinal ciliopathies through cross-species drug discovery using iPSC-derived organoids, highlights the impact of proteostasis in the pathogenesis of ciliopathies, and provides new insights for treatments of retinal neurodegeneration.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000053</institution-id><institution>National Eye Institute</institution></institution-wrap></funding-source><award-id>Z01EY000546</award-id><principal-award-recipient><name><surname>Swaroop</surname><given-names>Anand</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000053</institution-id><institution>National Eye Institute</institution></institution-wrap></funding-source><award-id>Z01EY000450</award-id><principal-award-recipient><name><surname>Swaroop</surname><given-names>Anand</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006108</institution-id><institution>National Center for Advancing Translational Sciences</institution></institution-wrap></funding-source><award-id>ZIATR000018-06</award-id><principal-award-recipient><name><surname>Zheng</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Holly Y Chen, Listed as inventor on a patent application related to the small molecules in this study by National Institutes of Health (PCT/US2021/040157).</p></fn><fn fn-type="conflict" id="conf3"><p>Manju Swaroop, Listed as inventor on a patent application related to the small molecules in this study by National Institutes of Health (PCT/US2021/040157).</p></fn><fn fn-type="conflict" id="conf4"><p>Samantha Papal, Listed as inventor on a patent application related to the small molecules in this study by National Institutes of Health (PCT/US2021/040157).</p></fn><fn fn-type="conflict" id="conf5"><p>Anupam Mondal, Listed as inventor on a patent application related to the small molecules in this study by National Institutes of Health (PCT/US2021/040157).</p></fn><fn fn-type="conflict" id="conf6"><p>Gregory Tawa, Listed as inventor on a patent application related to the small molecules in this study by National Institutes of Health (PCT/US2021/040157).</p></fn><fn fn-type="conflict" id="conf7"><p>Wei Zheng, Listed as inventor on a patent application related to the small molecules in this study by National Institutes of Health (PCT/US2021/040157).</p></fn><fn fn-type="conflict" id="conf8"><p>Anand Swaroop, Listed as inventor on a patent application related to the small molecules in this study by National Institutes of Health (PCT/US2021/040157).</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal procedures were approved by the Animal Care and Use committee of the National Eye Institutes (Animal study protocol NEI-650) and adhered to ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. RNA-seq data are available through GEO accession #206959.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Chen et al</collab></person-group><year iso-8601-date="2023">2023</year><source>NCBI Gene Expression Omnibus</source><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE206959">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE206959</ext-link><comment>NCBI Gene Expression Omnibus, GSE206959</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-83205-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>